Literature DB >> 9273380

Dislocation after bipolar hemiarthroplasty of the hip.

C L Barnes1, D J Berry, C B Sledge.   

Abstract

Although bipolar hemiarthroplasty of the hip is a frequently performed procedure, little information is available about the frequency of postoperative dislocation and its treatment. For this study, 1,934 hips treated consecutively with primary bipolar hemiarthroplasty were reviewed. A postoperative dislocation developed in 29 patients (1.5%): during the first month after surgery in 24 patients and between 1 month and 5 years after surgery in five patients. Of the 29 dislocations, 25 were successfully reduced with with routine closed methods. Among these 25 hips, 13 (52%) subsequently redislocated, and 7 of these required operative treatment for the recurrent dislocation. Dislocation after primary bipolar hemiarthroplasty is infrequent, can usually be reduced by routine closed methods, but is associated with a high rate of recurrent dislocation.

Entities:  

Mesh:

Year:  1995        PMID: 9273380     DOI: 10.1016/s0883-5403(05)80213-x

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  15 in total

1.  Dislocation of hip hemiarthroplasty following posterolateral surgical approach: a nested case-control study.

Authors:  Rami Madanat; Tatu J Mäkinen; Mikko T Ovaska; Martti Soiva; Tero Vahlberg; Jussi Haapala
Journal:  Int Orthop       Date:  2011-09-20       Impact factor: 3.075

2.  Is the dislocation rate higher after bipolar hemiarthroplasty in patients with neuromuscular diseases?

Authors:  Kuen Tak Suh; Dae Woong Kim; Hong Seok Lee; Yoon Jae Seong; Jung Sub Lee
Journal:  Clin Orthop Relat Res       Date:  2011-10-21       Impact factor: 4.176

3.  CORR Insights®: What Are the Risk Factors for Dislocation of Hip Bipolar Hemiarthroplasty Through the Anterolateral Approach? A Nested Case-control Study.

Authors:  Eckart Mayr
Journal:  Clin Orthop Relat Res       Date:  2016-09-28       Impact factor: 4.176

4.  Risk Factors Associated with Dislocation after Bipolar Hemiarthroplasty in Elderly Patients with Femoral Neck Fracture.

Authors:  Yeesuk Kim; Joon-Kuk Kim; Il-Han Joo; Kyu-Tae Hwang; Young-Ho Kim
Journal:  Hip Pelvis       Date:  2016-06-30

5.  Dislocation of bipolar hip hemiarthroplasty through a postero-lateral approach for femoral neck fractures: A cohort study.

Authors:  Sebastian Mukka; Jenny Lindqvist; Sara Peyda; Cyrus Brodén; Sarwar Mahmood; Hamid Hassany; Arkan Sayed-Noor
Journal:  Int Orthop       Date:  2015-01-06       Impact factor: 3.075

6.  What Are the Risk Factors for Dislocation of Hip Bipolar Hemiarthroplasty Through the Anterolateral Approach? A Nested Case-control Study.

Authors:  Lianhua Li; Jixin Ren; Jia Liu; Hao Wang; Qinghua Sang; Zhi Liu; Tiansheng Sun
Journal:  Clin Orthop Relat Res       Date:  2016-08-30       Impact factor: 4.176

7.  Treatment of femoral neck fractures in elderly patients over 60 years of age - which is the ideal modality of primary joint replacement?

Authors:  Christian Ossendorf; Max J Scheyerer; Guido A Wanner; Hans-Peter Simmen; Clément Ml Werner
Journal:  Patient Saf Surg       Date:  2010-10-20

Review 8.  A systematic review and meta-analysis of the direct anterior approach for hemiarthroplasty for femoral neck fracture.

Authors:  Samuel T Kunkel; Matthew J Sabatino; Ravinder Kang; David S Jevsevar; Wayne E Moschetti
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-08-29

9.  Low femoral antetorsion as a risk factor for bony impingement after bipolar hemiarthroplasty.

Authors:  Takeshi Shoji; Yuji Yasunaga; Takuma Yamasaki; Soutarou Izumi; Susumu Hachisuka; Mitsuo Ochi
Journal:  J Orthop Surg Res       Date:  2015-07-07       Impact factor: 2.359

10.  Cemented versus uncemented hemiarthroplasty for femoral neck fractures in patients with neuromuscular diseases: a minimum of 2 years' follow-up study.

Authors:  Yuchuan Wang; Zhongzheng Wang; Siyu Tian; Zhanchao Tan; Yanbin Zhu; Wei Chen; Yingze Zhang
Journal:  J Orthop Surg Res       Date:  2021-07-01       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.